
Glaukos Corporation GKOS
$ 143.0
0.6%
Quarterly report 2025-Q2
added 08-04-2025
Glaukos Corporation Operating Cycle 2011-2026 | GKOS
Annual Operating Cycle Glaukos Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 237 | 206 | 149 | 177 | 462 | 231 | 233 | 200 | 154 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 462 | 149 | 228 |
Quarterly Operating Cycle Glaukos Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 267 | 276 | - | - | - | - | 241 | 225 | 243 | - | - | 85.1 | 174 | 158 | 155 | 128 | 134 | 119 | 131 | 171 | 143 | 298 | 564 | 554 | 407 | 202 | 240 | 236 | 233 | 258 | 217 | 222 | 198 | - | 44.1 | 45.7 | 43.2 | - | 36.2 | 38.8 | 40.3 | - | 40.6 | 22.2 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 564 | 22.2 | 188 |
Operating Cycle of other stocks in the Medical instruments industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
282 | $ 60.84 | 0.76 % | $ 12.1 B | ||
|
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | ||
|
Luminex Corporation
LMNX
|
37.1 | - | - | $ 1.75 B | ||
|
ICU Medical
ICUI
|
185 | $ 122.4 | -0.48 % | $ 3.02 B | ||
|
iRhythm Technologies
IRTC
|
67.6 | $ 114.08 | -0.07 % | $ 3.65 B | ||
|
Akers Biosciences, Inc.
AKER
|
184 | - | -9.52 % | $ 20.6 M | ||
|
Intuitive Surgical
ISRG
|
227 | $ 428.24 | 0.04 % | $ 153 B | ||
|
Alcon
ALC
|
197 | $ 64.65 | 1.02 % | $ 40.4 B | ||
|
Repro Med Systems
KRMD
|
129 | $ 3.91 | -1.75 % | $ 181 M | ||
|
LeMaitre Vascular
LMAT
|
42.9 | $ 99.4 | -0.1 % | $ 2.25 B | ||
|
Masimo Corporation
MASI
|
168 | $ 178.41 | 0.03 % | $ 9.51 B | ||
|
Antares Pharma, Inc.
ATRS
|
234 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
571 | - | -1.18 % | $ 3.4 B | ||
|
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
495 | - | - | $ 28.6 M | ||
|
Envista Holdings Corporation
NVST
|
132 | $ 23.9 | 0.21 % | $ 4.02 B | ||
|
Varian Medical Systems, Inc.
VAR
|
227 | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
156 | $ 6.3 | -2.02 % | $ 53.4 K | ||
|
Haemonetics Corporation
HAE
|
258 | $ 57.35 | 0.46 % | $ 2.89 B | ||
|
Isoray
ISR
|
353 | - | 0.03 % | $ 108 M | ||
|
STAAR Surgical Company
STAA
|
38.2 | $ 31.91 | -0.31 % | $ 1.58 B | ||
|
STERIS plc
STE
|
144 | $ 216.15 | 0.08 % | $ 21.3 B | ||
|
Teleflex Incorporated
TFX
|
332 | $ 130.56 | 0.21 % | $ 5.83 B | ||
|
InfuSystem Holdings
INFU
|
90.5 | $ 8.43 | -2.37 % | $ 174 M | ||
|
Microbot Medical
MBOT
|
180 | $ 1.92 | 3.69 % | $ 87.9 M | ||
|
Milestone Scientific
MLSS
|
543 | $ 0.34 | -1.02 % | $ 27.9 M | ||
|
Merit Medical Systems
MMSI
|
198 | $ 62.37 | -0.3 % | $ 3.69 B | ||
|
Utah Medical Products
UTMD
|
339 | $ 63.24 | -0.72 % | $ 205 M | ||
|
West Pharmaceutical Services
WST
|
143 | $ 301.21 | 0.34 % | $ 21.8 B | ||
|
Pulse Biosciences
PLSE
|
189 | $ 25.45 | -6.09 % | $ 1.72 B | ||
|
DENTSPLY SIRONA
XRAY
|
120 | $ 10.1 | -3.03 % | $ 2.01 B | ||
|
Retractable Technologies
RVP
|
249 | $ 0.69 | -0.01 % | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
228 | $ 57.73 | -1.57 % | $ 190 M | ||
|
Predictive Oncology
POAI
|
96.5 | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
348 | $ 20.76 | -1.42 % | $ 991 M | ||
|
Stereotaxis
STXS
|
268 | $ 1.89 | -2.83 % | $ 172 M | ||
|
Baxter International
BAX
|
152 | $ 17.62 | -0.96 % | $ 9.04 B | ||
|
ResMed
RMD
|
202 | $ 204.91 | 1.21 % | $ 29.9 B | ||
|
AtriCure
ATRC
|
253 | $ 28.69 | 1.92 % | $ 1.37 B | ||
|
Harvard Bioscience
HBIO
|
285 | $ 5.34 | -3.26 % | $ 237 M | ||
|
NeuroMetrix
NURO
|
435 | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
220 | $ 10.98 | -0.45 % | $ 449 M | ||
|
Becton, Dickinson and Company
BDX
|
169 | $ 143.99 | -0.33 % | $ 41.4 B | ||
|
Nephros
NEPH
|
190 | $ 3.2 | -4.23 % | $ 34 M | ||
|
OraSure Technologies
OSUR
|
251 | $ 3.04 | 3.05 % | $ 223 M | ||
|
Repligen Corporation
RGEN
|
235 | $ 106.8 | 3.31 % | $ 6.01 M |